Option chain shows key data for Journey Medical's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Journey Medical.

Journey Medical (NASDAQ:DERM) Stock, Option Chain

Journey Medical

Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.

wall street chart shutter2

News

Short Ideas

Pre-Market Outlook

Markets

Trading Ideas

ALMS

CMRX

DERM

Top 3 Health Care Stocks That May Crash In Q2

A Different Picture

Movers

Journey Medical (NASDAQ:DERM) shares are trading higher Monday after the company announced the U.S. Food and Drug Administration approved its Emrosi drug for the treatment of rosacea.

What&#39;s Going On With Journey Medical Stock Today?

AGRI

AILE

BCDA

CELH

CLEU

CMLS

CRWD

EFSH

ENSV

ESPR

FCEL

GERN

GMGI

HOUS

HOVR

ICCH

LENZ

MLGO

NISN

NVAX

OPRA

PERI

PRST

RENB

ROMA

SBFM

SIFY

SKYE

SMHI

SPEC

SYNX

TELL

THAR

TNXP

TPHS

VRAX

WETH

WLDS

Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Journey Medical Corporation - Common Stock

Journey Medical Corp

DermTech Inc

DermTech Inc Warrants(20/06/2022)

Dermapharm Holding SE

Dermata Therapeutics, Inc. - Common Stock

Dermata Therapeutics Inc

Dermisonics Inc

Health Care

Press Releases

General

Journey Medical Corporation Launches Emrosi™ (40 mg Minocycline Hydrochloride Modified-Release Capsules, 10 mg immediate release and 30 mg extended release) for the Treatment of Rosacea

Earnings

Journey Medical Corporation Reports Full-Year 2024 Financial Results and Recent Corporate Highlights

Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights

Management

Journey Medical Corporation Appoints Ramsey Alloush as Chief Operating Officer

Journey Medical Corporation to Announce First Quarter 2025 Financial Results on May 14, 2025

Journey Medical Corporation Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Fortress Biotech Reports First Quarter 2025 Financial Results and Recent Corporate Highlights

Journey Medical Corporation Announces Emrosi™ Featured on "The Balancing Act" Airing on Lifetime TV

Journey Medical Corporation Announces Emrosi™ Data Analysis to be Presented at the Society of Dermatology Physician Associates (SDPA) 2025 Annual Summer Dermatology Conference

Journey Medical to Join Russell 2000® and Russell 3000® Indexes

CKPT

FBIO

FBIOP

Aclaris Therapeutics, Inc. - Common Stock

Aclaris Therapeutics

ALT5 Sigma

Alto Neuroscience

Atea Pharmaceuticals, Inc. - common stock

Atea Pharmaceuticals

Bioage Labs

Biote

Contineum Therapeutics, Inc. - Common stock

Contineum Therapeutics

Esperion Therapeutics, Inc. - Common Stock

Esperion Therapeutics

Ikena Oncology

Milestone Pharmaceuticals Inc. - Common Shares

Milestone Pharmaceuticals

Nektar Therapeutics

Neumora Therapeutics, Inc. - Common Stock

Neumora Therapeutics

NeOnc Technologies Holdings, Inc. - Common Stock

NeOnc Technologies

Nutriband

Omeros

Oramed Pharmaceuticals Inc. - Common Stock

Oramed Pharmaceuticals

Pliant Therapeutics

Regencell Bioscience Holdings Limited - Ordinary Shares

Regencell Bioscience

Cassava Sciences

scPharmaceuticals

China SXT Pharmaceuticals, Inc. - Common Stock

China SXT Pharmaceuticals

Third Harmonic Bio

Tvardi Therapeutics

Veru

Ventyx Biosciences

Lake Street

Rodman & Renshaw

Roth MKM

Alliance Global Partners

B. Riley Securities

Comments

Journey Medical

Journey Medical (DERM) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell